Dual expert sessions: 2 x 30 minutes
Wednesday, November 10th 2021
Join leading experts in microfluidic polymer and glass diagnostics for this deep dive into microfluidic diagnostics development. The two sessions blend commercial and technical subjects across IVD manufacturing and microarray development.
High-precision 3D-glass components for diagnostics
We are happy to announce that the joint project between SCHOTT Technical Glass Solutions GmbH, LensTec Jena GmbH and the Fraunhofer Insitute for Applied Optics and Precision Engineering IOF is receiving support from the European Regional Development Fund.
28 September 2021, Germany, Mainz
- The acquisition of the Arizona-based microarray solutions company extends SCHOTT’s manufacturing presence in the United States and strengthens its bioscience capabilities.
- Customers will benefit from enhanced development and manufacture capabilities including high-density microarray printing.
SCHOTT MINIFAB is pleased to be exhibiting again at JACLaS 2021. Click here for more info >
AACC is finally back and SCHOTT MINIFAB is pleased to be exhibiting again in 2021. Click here for more info >
Dual expert session: Polymer Prototyping and Complex 3D Glass Structuring
WATCH RECORDING FROM: Thursday, 2nd September 2021
Join leading experts in microfluidic polymer and glass diagnostics for this deep dive into microfluidic diagnostics development. The two sessions focus on how good practices in prototyping and early-stage manufacturing reduce costs, complexity and risk in both the short and long term. Session one will deliver insights into best practice prototyping for polymer microfluidic devices. Session two will outline in detail how laser-enabled glass structuring and bonding can help deliver lower-cost glass microfluidics.
In April 2021, Qorvo were granted emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the Qorvo Omnia™ SARS-CoV-2 Antigen Test. The EUA approval is a major milestone in the collaboration between Qorvo and SCHOTT MINIFAB over the past two years.
FREE WEBINAR - 3 x 20 MINUTE EXPERT SESSIONS
Point-of-Care diagnostic consumable development: Don’t underestimate the importance of biochemistry expertise!
It is without question that the global pandemic has created an explosion in the demand for automated point-of-care consumables. In the face of this demand, the race to launch new innovative diagnostics has never been run at a faster pace.
However, significant challenges remain in translating lab-based assays onto automated high-performance consumables. Foremost among these are the challenges presented by the integration and optimization of biochemistries. Indeed, it is probably the single most underestimated step toward successfully developing and commercializing a diagnostic consumable.
Through three 15-minute segments followed by a Q&A, this educational webinar addresses best practices in overcoming these development challenges by three thought leaders in this field.
Specifically, participants can expect to learn:
- Fundamental elements of the process for successful assay translation through an early design perspective.
- A universal workflow for complex microarray development and performance optimization
- The performance advantages of nanoparticle bioconjugation in point-of-care assay development
Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.